Northern Trust’s Bioventus BVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$2.61M Buy
394,164
+14,147
+4% +$93.7K ﹤0.01% 2840
2025
Q1
$3.48M Buy
380,017
+34,101
+10% +$312K ﹤0.01% 2617
2024
Q4
$3.63M Buy
345,916
+23,523
+7% +$247K ﹤0.01% 2699
2024
Q3
$3.85M Buy
322,393
+227,381
+239% +$2.72M ﹤0.01% 2632
2024
Q2
$546K Buy
95,012
+15,947
+20% +$91.7K ﹤0.01% 3474
2024
Q1
$411K Sell
79,065
-10,014
-11% -$52.1K ﹤0.01% 3627
2023
Q4
$469K Buy
89,079
+11,065
+14% +$58.3K ﹤0.01% 3555
2023
Q3
$257K Buy
78,014
+8,239
+12% +$27.2K ﹤0.01% 3718
2023
Q2
$202K Sell
69,775
-204,022
-75% -$590K ﹤0.01% 3826
2023
Q1
$293K Buy
273,797
+587
+0.2% +$628 ﹤0.01% 3677
2022
Q4
$713K Sell
273,210
-1,783
-0.6% -$4.65K ﹤0.01% 3380
2022
Q3
$1.93M Buy
274,993
+3,838
+1% +$26.9K ﹤0.01% 3032
2022
Q2
$1.85M Buy
271,155
+24,608
+10% +$168K ﹤0.01% 3108
2022
Q1
$3.48M Sell
246,547
-12,352
-5% -$174K ﹤0.01% 2794
2021
Q4
$3.75M Buy
258,899
+121,887
+89% +$1.77M ﹤0.01% 2875
2021
Q3
$1.94M Buy
137,012
+42,987
+46% +$609K ﹤0.01% 3305
2021
Q2
$1.66M Buy
94,025
+706
+0.8% +$12.4K ﹤0.01% 3408
2021
Q1
$1.43M Buy
+93,319
New +$1.43M ﹤0.01% 3429